IL10 and colitis: By contrast, although NAC significantly stimulated CAT activity and increased GSH and decreased GSSG levels, consequently improving the GSH/GSSG ratio, its administration leads to increased MDA levels (vs. the control and colitis groups) and decreased anti-inflammatory capacity in the kidney, by reducing IL-10 levels (Figures 8 and 9).